M B Sugars And Pharmaceuticals Private Limited, a active private limited company, was established on 02 February 1996 in Nashik, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U15420MH1996PTC096832. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.32 M.
Formerly known as M B Sugars And Pharmaceuticals Limited. It upholds a compliant status. Employing 201 professional, Its leadership includes Rushabh Anilkumar Lodha (Director), Dineshkumar Bhagchand Lodha (Director), Vijaykumar Bhagchand Lodha (Managing Director). Past directors included Bhagchand Motilal Lodha. It holds ₹67.35 Cr open charges and ₹32.28 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Lodha Bhavanp B No 31 Malegaon, Nashik, Maharashtra, 423203.
U15420MH1996PTC096832
096832
02 February 1996
₹1.00 Cr
₹7.32 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into M B Sugars And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rushabh Anilkumar Lodha | Director | 01 Apr 2008 | Current |
| Dineshkumar Bhagchand Lodha | Director | 02 Feb 1996 | Current |
| Vijaykumar Bhagchand Lodha | Managing Director | 02 Feb 1996 | Current |
| Saurabh Dineshkumar Lodha | Director | 14 Mar 2019 | Current |
| Samyak Vijaykumar Lodha | Director | 06 Jun 2007 | Current |
| Anilkumar Bhagchand Lodha | Director | 02 Feb 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Oct 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
M B Sugars And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.3% increase. The company also saw a substantial improvement in profitability, with a 662.61% increase in profit. The company's net worth Soared by an impressive increase of 185.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, M B Sugars And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹673,505,500.00
₹322,805,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2025 | Others | ₹15.00 Cr | Open |
| 09 Apr 2024 | Others | ₹1.35 Cr | Open |
| 09 Apr 2024 | Others | ₹1.35 Cr | Open |
| 29 Mar 2024 | Others | ₹1.35 Cr | Open |
| 07 Nov 2023 | Others | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
M B Sugars And Pharmaceuticals has a workforce of 201 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of M B Sugars And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M B Sugars And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101146026 was registered on 28 Aug 2025. was documented.
The activity A charge registered on 19 Oct 2022 via Charge ID 100621386 with Others was fully satisfied on 04 Apr 2025. was completed.
A charge registered on 25 Jun 2015 via Charge ID 10591086 with Dbs Bank Ltd was fully satisfied on 04 Apr 2025. was recorded as a recent event.
Progress on A charge registered on 25 Jun 2015 via Charge ID 10591084 with Dbs Bank Ltd was fully satisfied on 04 Apr 2025. was documented.
Progress on A charge registered on 08 Jan 2020 via Charge ID 100313420 with Others was fully satisfied on 03 Apr 2025. was documented.
Progress on M B Sugars And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of M B Sugars And Pharmaceuticals Private Limited is U15420MH1996PTC096832.
M B Sugars And Pharmaceuticals Private Limited is headquartered at Lodha Bhavanp B No 31 Malegaon, Nashik, Maharashtra, 423203.
M B Sugars And Pharmaceuticals Private Limited was incorporated on 02 February 1996.
The current directors of M B Sugars And Pharmaceuticals Private Limited are
The primary industry of M B Sugars And Pharmaceuticals Private Limited is Manufacturing.
M B Sugars And Pharmaceuticals Private Limited is unlisted.
The authorized capital of M B Sugars And Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.32 M.
The compliance status of M B Sugars And Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX